NCT02775981View on ClinicalTrials.gov

Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Analgesic Allergy
Interventions
DRUG

RX0041-002

Trial Locations (1)

08009

Comprehensive Clinical Researc, Berlin

Sponsors
All Listed Sponsors
collaborator

Cognitive Research Corporation

INDUSTRY

lead

Pharmaceutical Project Solutions, Inc.

INDUSTRY